These drugs --Trastuzumab Deruxtecan, Osimertinib, and Durvalumab -- are manufactured by AstraZeneca plc, a British-Swedish multinational pharmaceutical and biotechnology company, and supplied in India by its subsidiary, AstraZeneca Pharma India Limited, based in Bengaluru.

Union Budget 2024: AstraZeneca set to gain from customs duty exemption on key cancer drugs in full Budget

The company’s margin contracts 972 basis points to 4.92% in the quarter ended December.

AstraZeneca Pharma Shares Plunge 14% To One-Month Low After Q3 Profit Dips 46%

AstraZeneca Pharma India Plans To Sell Bengaluru Manufacturing Plant, AstraZeneca Pharma India will position the manufacturing site for sale in a fully operational manner and begin a search for a buyer who can also act as CMO for its products

AstraZeneca Pharma India Plans To Sell Bengaluru Manufacturing Plant, Check Details - News18

ITC Ltd, Vodafone Idea Ltd, Indiabulls Housing Finance, KNR Constructions Ltd, AstraZeneca Pharma India, Wockhardt Ltd and Saksoft Ltd are among a handful of companies that will announce their quarterly results today.

Gift Nifty signals a tepid start: ITC, Vodafone Idea Q1 results; stocks in F&O ban; TVS Supply IPO & more

ITC Ltd, Vodafone Idea Ltd, Indiabulls Housing Finance, KNR Constructions Ltd, AstraZeneca Pharma India, Wockhardt Ltd, Saksoft Ltd and Uflex are among a handful of companies that will announce their quarterly results today.

Stocks in news: ITC, Adani Ports, Tata Steel, Nykaa, Vodafone Idea, HDFC Bank & CarTrade

The company already received Import and Market Permission in Form CT-20 from the Drugs Controller General of India.

AstraZeneca Pharma shares gain on pediatric drug launch in India

Voltas.L&T board meets to consider Q1 results, buyback & special dividend; RIL, Brookfield & Digital Realty form JV for data centres; Maruti Suzuki recalls 87,599 vehicles; AstraZeneca Pharma gets approval for heart failure drug; RIL, Brookfield & Digital Realty to set up data centres; Tiger Logisti…

Stocks that will see action today: July 25, 2023

AstraZeneca Pharma India on Monday said it has received approval from the Drugs Controller General of India to import heart failure treatment drug Dapagliflozin tablets. The company has received permission from the DCGI to import pharmaceutical formulations of a new drug for sale, the drug firm said…

AstraZeneca gets GCGI approval to import heart failure drug

The receipt of this permission paves way for the launch of Tremelimumab solution of 20 mg/ml in India. Tremelimumab, in combination with Durvalumab (Imfinzi), is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC).

AstraZeneca Pharma shares gain 3% on CDSCO approval for sale of Tremelimumab

AstraZeneca Pharma India on Thursday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its cancer drug Tremelimumab Concentrate to be administered intravenously.

AstraZeneca receives CDSCO’s approval for cancer drug Tremelimumab

Trastuzumab deruxtecan is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi Sankyo

AstraZeneca Pharma India receives DCGI’s approval for import of cancer drug

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.